Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

November 01, 2009; Volume 331,Issue 2

HIGHLIGHTED PAPER

  • You have access
    Inflammation Gender Differences in Heart Disease Patients
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 339;

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Allosteric Modulators of G Protein-Coupled Receptors: Future Therapeutics for Complex Physiological Disorders
    Liyun Wang, Bronwen Martin, Randall Brenneman, Louis M. Luttrell and Stuart Maudsley
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 340-348; DOI: https://doi.org/10.1124/jpet.109.156380

BEHAVIORAL PHARMACOLOGY

  • You have access
    Extracellular Signal-Regulated Kinase 1/2 Activation Counteracts Morphine Tolerance in the Periaqueductal Gray of the Rat
    Tara A. Macey, Erin N. Bobeck, Deborah M. Hegarty, Sue A. Aicher, Susan L. Ingram and Michael M. Morgan
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 412-418; DOI: https://doi.org/10.1124/jpet.109.152157
  • You have access
    Cocaine Esterase Prevents Cocaine-Induced Toxicity and the Ongoing Intravenous Self-Administration of Cocaine in Rats
    Gregory T. Collins, Remy L. Brim, Diwahar Narasimhan, Mei-Chuan Ko, Roger K. Sunahara, Chang-Guo Zhan and James H. Woods
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 445-455; DOI: https://doi.org/10.1124/jpet.108.150029
  • You have access
    Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane (DOM), Ketanserin, and (R)-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in Rats
    Jun-Xu Li, Alison Unzeitig, Martin A. Javors, Kenner C. Rice, Wouter Koek and Charles P. France
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 671-679; DOI: https://doi.org/10.1124/jpet.109.157560
  • You have access
    Anxiolytic Effects of Phosphodiesterase-2 Inhibitors Associated with Increased cGMP Signaling
    Anbrin Masood, Ying Huang, Hassan Hajjhussein, Lan Xiao, Hao Li, Wei Wang, Adel Hamza, Chang-Guo Zhan and James M. O'Donnell
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 690-699; DOI: https://doi.org/10.1124/jpet.109.156729
  • You have access
    Discriminative Stimulus Effects of Psychostimulants and Hallucinogens in S(+)-3,4-Methylenedioxymethamphetamine (MDMA) and R(−)-MDMA Trained Mice
    K. S. Murnane, N. Murai, L. L. Howell and W. E. Fantegrossi
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 717-723; DOI: https://doi.org/10.1124/jpet.109.156174

CARDIOVASCULAR

  • You have access
    Ranolazine Antagonizes the Effects of Increased Late Sodium Current on Intracellular Calcium Cycling in Rat Isolated Intact Heart
    J. Andrew Wasserstrom, Rohan Sharma, Matthew J. O'Toole, Jiabo Zheng, James E. Kelly, John Shryock, Luiz Belardinelli and Gary L. Aistrup
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 382-391; DOI: https://doi.org/10.1124/jpet.109.156471
  • You have access
    Targeted Detoxification of Selected Reactive Oxygen Species in the Vascular Endothelium
    Vladimir V. Shuvaev, Melpo Christofidou-Solomidou, Faiz Bhora, Karine Laude, Hua Cai, Sergei Dikalov, Evguenia Arguiri, Charalambos C. Solomides, Steven M. Albelda, David G. Harrison and Vladimir R. Muzykantov
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 404-411; DOI: https://doi.org/10.1124/jpet.109.156877
  • You have access
    Natural Variation within the Neuronal Nicotinic Acetylcholine Receptor Cluster on Human Chromosome 15q24: Influence on Heritable Autonomic Traits in Twin Pairs
    Brinda K. Rana, Jennifer Wessel, Vafa Mahboubi, Fangwen Rao, Jeannine Haeller, Jiaur R. Gayen, Eleazar Eskin, Anne M. Valle, Madhusudan Das, Sushil K. Mahata, Laurent Taupenot, Mats Stridsberg, Todd T. Talley, Michael G. Ziegler, Douglas W. Smith, Nicholas J. Schork, Daniel T. O'Connor and Palmer Taylor
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 419-428; DOI: https://doi.org/10.1124/jpet.109.157271
  • You have access
    Participation of Oxidative Stress on Rat Middle Cerebral Artery Changes Induced by Focal Cerebral Ischemia: Beneficial Effects of 3,4-Dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6)
    Francesc Jiménez-Altayó, Laura Caracuel, Fernando J. Pérez-Asensio, Sonia Martínez-Revelles, Ángel Messeguer, Anna M. Planas and Elisabet Vila
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 429-436; DOI: https://doi.org/10.1124/jpet.109.157131
  • You have access
    Enhanced Peroxisome Proliferator-Activated Receptor-γ Expression in Monocyte/Macrophages from Coronary Artery Disease Patients and Possible Gender Differences
    Angela Amoruso, Claudio Bardelli, Luigia G. Fresu, Alessandra Palma, Matteo Vidali, Valeria Ferrero, Flavio Ribichini, Corrado Vassanelli and Sandra Brunelleschi
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 531-538; DOI: https://doi.org/10.1124/jpet.109.154419

CELLULAR AND MOLECULAR

  • You have access
    Novel Peptide Antagonists of Adrenomedullin and Calcitonin Gene-Related Peptide Receptors: Identification, Pharmacological Characterization, and Interactions with Position 74 in Receptor Activity-Modifying Protein 1/3
    Samuel D. Robinson, Jacqueline F. Aitken, Richard J. Bailey, David R. Poyner and Debbie L. Hay
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 513-521; DOI: https://doi.org/10.1124/jpet.109.156448
  • You have access
    Tamoxifen Inhibits Inward Rectifier K+ 2.x Family of Inward Rectifier Channels by Interfering with Phosphatidylinositol 4,5-Bisphosphate-Channel Interactions
    Daniela Ponce-Balbuena, Angélica López-Izquierdo, Tania Ferrer, Aldo A. Rodríguez-Menchaca, Iván A. Aréchiga-Figueroa and José A. Sánchez-Chapula
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 563-573; DOI: https://doi.org/10.1124/jpet.109.156075
  • You have access
    Interaction of New, Very Potent Non-Nucleotide Antagonists with Arg256 of the Human Platelet P2Y12 Receptor
    Kristina Hoffmann, Younis Baqi, María Sol Morena, Markus Glänzel, Christa E. Müller and Ivar von Kügelgen
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 648-655; DOI: https://doi.org/10.1124/jpet.109.156687
  • You have access
    Thioflavin S (NSC71948) Interferes with Bcl-2-Associated Athanogene (BAG-1)-Mediated Protein-Protein Interactions
    Adam Sharp, Simon J. Crabb, Peter W. M. Johnson, Angela Hague, Ramsey Cutress, Paul A. Townsend, A. Ganesan and Graham Packham
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 680-689; DOI: https://doi.org/10.1124/jpet.109.153601
  • You have access
    Early Effects of Lasonolide A on Pancreatic Cancer Cells
    Richard A. Isbrucker, Esther A. Guzmán, Tara P. Pitts and Amy E. Wright
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 733-739; DOI: https://doi.org/10.1124/jpet.109.155531
  • You have access
    Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
    Amadeu Gavaldà, Montserrat Miralpeix, Israel Ramos, Raquel Otal, Cristina Carreño, Marisa Viñals, Teresa Doménech, Carla Carcasona, Blanca Reyes, Dolors Vilella, Jordi Gras, Julio Cortijo, Esteban Morcillo, Jesús Llenas, Hamish Ryder and Jorge Beleta
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 740-751; DOI: https://doi.org/10.1124/jpet.109.151639

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

  • You have access
    Characterization of Novel Diaryl Oxazole-Based Compounds as Potential Agents to Treat Pancreatic Cancer
    Arthur Y. Shaw, Meredith C. Henderson, Gary Flynn, Betty Samulitis, Haiyong Han, Steve P. Stratton, H.-H. Sherry Chow, Laurence H. Hurley and Robert T. Dorr
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 636-647; DOI: https://doi.org/10.1124/jpet.109.156406

ENDOCRINE AND DIABETES

  • You have access
    Cav1.2 and Cav1.3 Are Differentially Coupled to Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion in the Pancreatic β-Cell Line INS-1
    Sarah Melissa P. Jacobo, Marcy L. Guerra and Gregory H. Hockerman
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 724-732; DOI: https://doi.org/10.1124/jpet.109.158519

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    Peroxisome Proliferator-Activated Receptor γ Activation Alleviates Postoperative Ileus in Mice by Inhibition of Egr-1 Expression and Its Downstream Target Genes
    Ole De Backer, Ellen Elinck, Evelien Priem, Luc Leybaert and Romain A. Lefebvre
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 496-503; DOI: https://doi.org/10.1124/jpet.109.155135
  • You have access
    (R)-(3-Amino-2-fluoropropyl) Phosphinic Acid (AZD3355), a Novel GABAB Receptor Agonist, Inhibits Transient Lower Esophageal Sphincter Relaxation through a Peripheral Mode of Action
    Anders Lehmann, Madeleine Antonsson, Ann Aurell Holmberg, L. Ashley Blackshaw, Lena Brändén, Hans Bräuner-Osborne, Bolette Christiansen, John Dent, Thomas Elebring, Britt-Marie Jacobson, Jörgen Jensen, Jan P. Mattsson, Karolina Nilsson, Simo S. Oja, Amanda J. Page, Pirjo Saransaari and Sverker von Unge
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 504-512; DOI: https://doi.org/10.1124/jpet.109.153593

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

  • You have access
    Periodic, Partial Inhibition of IκB Kinase β-Mediated Signaling Yields Therapeutic Benefit in Preclinical Models of Rheumatoid Arthritis
    Kathleen M. Gillooly, Mark A. Pattoli, Tracy L. Taylor, Laishun Chen, Lihong Cheng, Kurt R. Gregor, Gena S. Whitney, Vojkan Susulic, Scott H. Watterson, James Kempson, William J. Pitts, Hollie Booth-Lute, Guchen Yang, Paul Davies, Daniel W. Kukral, Joann Strnad, Kim W. McIntyre, Celia J. Darienzo, Luisa Salter-Cid, Zheng Yang, David B. Wang-Iverson and James R. Burke
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 349-360; DOI: https://doi.org/10.1124/jpet.109.156018
  • You have access
    Apoptotic Signaling Activated by Modulation of the F0F1-ATPase: Implications for Selective Killing of Autoimmune Lymphocytes
    Thomas B. Sundberg, Lara Swenson, Daniel R. Wahl, Anthony W. Opipari and Gary D. Glick
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 437-444; DOI: https://doi.org/10.1124/jpet.109.156422
  • You have access
    E6201 [(3S,4R,5Z,8S,9S,11E)-14-(Ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione], a Novel Kinase Inhibitor of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase (MEK)-1 and MEK Kinase-1: In Vitro Characterization of Its Anti-Inflammatory and Antihyperproliferative Activities
    Masaki Goto, Jesse Chow, Kenzo Muramoto, Ken-ichi Chiba, Satoshi Yamamoto, Masanori Fujita, Hiroshi Obaishi, Kenji Tai, Yoshiharu Mizui, Isao Tanaka, Donna Young, Hua Yang, Yuan J. Wang, Hiroshi Shirota and Fabian Gusovsky
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 485-495; DOI: https://doi.org/10.1124/jpet.109.156554
  • You have access
    Pentoxifylline Prevents Loss of PP2A Phosphatase Activity and Recruitment of Histone Acetyltransferases to Proinflammatory Genes in Acute Pancreatitis
    Juan Sandoval, Javier Escobar, Javier Pereda, Natalia Sacilotto, José Luis Rodriguez, Luis Sabater, Luis Aparisi, Luis Franco, Gerardo López-Rodas and Juan Sastre
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 609-617; DOI: https://doi.org/10.1124/jpet.109.157537
  • You have access
    Prostaglandin E2 Inhibits Advanced Glycation End Product-Induced Adhesion Molecule Expression, Cytokine Production, and Lymphocyte Proliferation in Human Peripheral Blood Mononuclear Cells
    Hideo Kohka Takahashi, Keyue Liu, Hidenori Wake, Shuji Mori, Jiyong Zhang, Rui Liu, Tadashi Yoshino and Masahiro Nishibori
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 656-670; DOI: https://doi.org/10.1124/jpet.109.157594
  • You have access
    A Novel Indole-3-propanamide Exerts Its Immunosuppressive Activity by Inhibiting JAK3 in T Cells
    Delphine Carbonnelle, Muriel Duflos, Pascal Marchand, Catherine Chauvet, Jean-Yves Petit and François Lang
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 710-716; DOI: https://doi.org/10.1124/jpet.109.155986

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

  • You have access
    Mechanism-Based Inactivation of CYP2B1 and Its F-Helix Mutant by Two tert-Butyl Acetylenic Compounds: Covalent Modification of Prosthetic Heme Versus Apoprotein
    Hsia-lien Lin, Haoming Zhang, Kathleen R. Noon and Paul F. Hollenberg
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 392-403; DOI: https://doi.org/10.1124/jpet.109.158782
  • You have access
    Pharmacokinetic-Pharmacodynamic and Response Sensitization Modeling of the Intraocular Pressure-Lowering Effect of the EP4 Agonist 5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate (PF-04475270)
    Kenneth T. Luu, Eric Y. Zhang, Ganesh Prasanna, Cathie Xiang, Scott Anderson, Jay Fortner and Paolo Vicini
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 627-635; DOI: https://doi.org/10.1124/jpet.109.157800
  • You have access
    Lymphatic Transport of Methylnortestosterone Undecanoate (MU) and the Bioavailability of Methylnortestosterone Are Highly Sensitive to the Mass of Coadministered Lipid after Oral Administration of MU
    Karen L. White, Gary Nguyen, William N. Charman, Glenn A. Edwards, W. A. (Fried) Faassen and Christopher J. H. Porter
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 700-709; DOI: https://doi.org/10.1124/jpet.109.154542

NEUROPHARMACOLOGY

  • You have access
    Capsaicin Protects Mouse Neuromuscular Junctions from the Neuroparalytic Effects of Botulinum Neurotoxin A
    Baskaran Thyagarajan, Natalia Krivitskaya, Joseph G. Potian, Kormakur Hognason, Carmen C. Garcia and Joseph J. McArdle
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 361-371; DOI: https://doi.org/10.1124/jpet.109.156901
  • You have access
    In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor α5 Subtype-Selective Inverse Agonist
    John R. Atack, Karen A. Maubach, Keith A. Wafford, Desmond O'Connor, A. David Rodrigues, David C. Evans, F. David Tattersall, Mark S. Chambers, Angus M. MacLeod, Wai-Si Eng, Christine Ryan, Eric Hostetler, Sandra M. Sanabria, Raymond E. Gibson, Stephen Krause, H. Donald Burns, Richard J. Hargreaves, Nancy G. B. Agrawal, Ruth M. McKernan, M. Gail Murphy, Kevin Gingrich, Gerard R. Dawson, Donald G. Musson and Kevin J. Petty
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 470-484; DOI: https://doi.org/10.1124/jpet.109.157636
  • You have access
    Neuroprotection by Tosyl-Polyamine Derivatives through the Inhibition of Ionotropic Glutamate Receptors
    Takashi Masuko, Rie Namiki, Yuta Nemoto, Muneharu Miyake, Yasuo Kizawa, Toyofumi Suzuki, Keiko Kashiwagi, Kazuei Igarashi and Tadashi Kusama
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 522-530; DOI: https://doi.org/10.1124/jpet.109.152926
  • You have access
    Immunoneutralization of Agmatine Sensitizes Mice to μ-Opioid Receptor Tolerance
    Carrie L. Wade, Lori L. Eskridge, H. Oanh X. Nguyen, Kelley F. Kitto, Laura S. Stone, George Wilcox and Carolyn A. Fairbanks
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 539-546; DOI: https://doi.org/10.1124/jpet.109.155424
  • You have access
    The Role of α6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal
    K. J. Jackson, J. M. McIntosh, D. H. Brunzell, S. S. Sanjakdar and M. I. Damaj
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 547-554; DOI: https://doi.org/10.1124/jpet.109.155457
  • You have access
    Extended Methamphetamine Self-Administration in Rats Results in a Selective Reduction of Dopamine Transporter Levels in the Prefrontal Cortex and Dorsal Striatum Not Accompanied by Marked Monoaminergic Depletion
    Marek Schwendt, Angelica Rocha, Ronald E. See, Alejandra M. Pacchioni, Jacqueline F. McGinty and Peter W. Kalivas
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 555-562; DOI: https://doi.org/10.1124/jpet.109.155770
  • You have access
    Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
    Steven M. Grauer, Virginia L. Pulito, Rachel L. Navarra, Michele P. Kelly, Cody Kelley, Radka Graf, Barbara Langen, Sheree Logue, Julie Brennan, Lixin Jiang, Erik Charych, Ute Egerland, Feng Liu, Karen L. Marquis, Michael Malamas, Thorsten Hage, Thomas A. Comery and Nicholas J. Brandon
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 574-590; DOI: https://doi.org/10.1124/jpet.109.155994
  • You have access
    Blockade of 2-Arachidonoylglycerol Hydrolysis by Selective Monoacylglycerol Lipase Inhibitor 4-Nitrophenyl 4-(Dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances Retrograde Endocannabinoid Signaling
    Bin Pan, Wei Wang, Jonathan Z. Long, Dalong Sun, Cecilia J. Hillard, Benjamin F. Cravatt and Qing-song Liu
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 591-597; DOI: https://doi.org/10.1124/jpet.109.158162
  • You have access
    Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer's Disease
    Robert L. Martone, Hua Zhou, Kevin Atchison, Thomas Comery, Jane Z. Xu, Xinyi Huang, Xioahai Gong, Mei Jin, Anthony Kreft, Boyd Harrison, Scott C. Mayer, Suzan Aschmies, Cathleen Gonzales, Margaret M. Zaleska, David R. Riddell, Erik Wagner, Peimin Lu, Shaiu-Ching Sun, June Sonnenberg-Reines, Aram Oganesian, Karissa Adkins, Michael W. Leach, David W. Clarke, Donna Huryn, Magid Abou-Gharbia, Ronald Magolda, Jonathan Bard, Glen Frick, Sangeeta Raje, S. Bradley Forlow, Carrie Balliet, Michael E. Burczynski, Peter H. Reinhart, Hong I. Wan, Menelas N. Pangalos and J. Steven Jacobsen
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 598-608; DOI: https://doi.org/10.1124/jpet.109.152975
  • You have access
    N-Methyl-d-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 Synapse
    Blaise Mathias Costa, Bihua Feng, Timur S. Tsintsadze, Richard M. Morley, Mark W. Irvine, Vera Tsintsadze, Natasha A. Lozovaya, David E. Jane and Daniel T. Monaghan
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 618-626; DOI: https://doi.org/10.1124/jpet.109.156752
  • You have access
    Comparison of the Effects of Central and Peripheral Dopamine Receptor Activation on Evoked Firing in the Trigeminocervical Complex
    Annabelle R Charbit, Simon Akerman and Peter J Goadsby
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 752-763; DOI: https://doi.org/10.1124/jpet.109.151951

TOXICOLOGY

  • You have access
    “Danger” Conditions Increase Sulfamethoxazole-Protein Adduct Formation in Human Antigen-Presenting Cells
    S. N. Lavergne, H. Wang, H. E. Callan, B. K. Park and D. J. Naisbitt
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 372-381; DOI: https://doi.org/10.1124/jpet.109.155374
  • You have access
    Increased Sensitivity of Glutathione S-Transferase P-Null Mice to Cyclophosphamide-Induced Urinary Bladder Toxicity
    Daniel J. Conklin, Petra Haberzettl, Jean-Francois Lesgards, Russell A. Prough, Sanjay Srivastava and Aruni Bhatnagar
    Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 456-469; DOI: https://doi.org/10.1124/jpet.109.156513
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 331 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 331, Issue 2
1 Nov 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • HIGHLIGHTED PAPER
  • PERSPECTIVES IN PHARMACOLOGY
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY
  • ENDOCRINE AND DIABETES
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA
  • METABOLISM, TRANSPORT, AND PHARMACOGENOMICS
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Most Read
Loading
  • Manifestations of METH Neurotoxicity
  • Ocular Drug Delivery: Past, Present, and Future
  • Noradrenergic Mechanisms in Fentanyl Rapid Death
  • Acalabrutinib: A Differentiated Covalent BTK Inhibitor
  • Cannabis Therapy for Refractory Epilepsy
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics